Brian D. Furmanski

Phase I Pharmacokinetic and Pharmacodynamic Study of the Multikinase Inhibitor Sorafenib in Combination With Clofarabine and Cytarabine in Pediatric Relapsed/Refractory Leukemia

Hiroto Inaba, Jeffrey E. Rubnitz, Elaine Coustan‐Smith et al. · Journal of Clinical Oncology · 2011 · 149 citations · Full text

Model-informed drug development approach supporting approval of the 4-week (Q4W) dosing schedule for nivolumab (Opdivo) across multiple indications: a regulatory perspective

Youwei Bi, Jun-Qiao Liu, Brian D. Furmanski et al. · Annals of Oncology · 2019 · 59 citations · Full text

Contribution of Abcc4-Mediated Gastric Transport to the Absorption and Efficacy of Dasatinib

Brian D. Furmanski, Shuiying Hu, Ken‐ichi Fujita et al. · Clinical Cancer Research · 2013 · 45 citations

Biological activities of fusarochromanone: a potent anti-cancer agent

Elahe Mahdavian, Phillip Palyok, Steven Adelmund et al. · BMC Research Notes · 2014 · 19 citations · Full text